FIELD: medicine.
SUBSTANCE: invention refers to medicine. There are applied at least two proteases for preparing a drug for treating and/or preventing ocular diseases related to neoangiogenesis and specified in a group consisting of age-related macular degeneration (AMD), choroidal revascularization, Von Hippel-Lindau disease, iris revascularisation, ischemic proliferative retinopathy, corneal revascularisation, and proliferative crescent cell retinopathy wherein at least one protease is specified in a group consisting of a group consisting of herbal protease.
EFFECT: invention provides reducing angiogenesis in treating or preventing ocular diseases related to neoangiogenesis.
14 cl, 1 tbl, 7 dwg, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL PREPARATION FOR TREATING BENIGN PROSTATIC HYPERPLASIA | 2008 |
|
RU2485971C2 |
| APPLYING BIS-PHOSPHONIC ACIDS FOR TREATMENT OF ANGIOGENESIS | 2000 |
|
RU2261100C2 |
| COMBINED THERAPY BY USING ANTIANGIOGENIC AGENTS AND TNF-ALPHA | 2002 |
|
RU2316337C2 |
| PYRROLE SUBSTITUTED INDOLONE DERIVATIVE, METHOD OF ITS PREPARATION INCLUDING ITS COMPOSITION AND APPLICATION | 2015 |
|
RU2650682C2 |
| CHIMERIC PROTEINS, INHIBITING ANGIOGENESIS, AND THEIR APPLICATION | 2005 |
|
RU2355414C2 |
| HUMAN PROTEIN TYROSINE PHOSPHATASE BETA BINDING ANTIBODIES (HPTPBETA), AND USE THEREOF | 2007 |
|
RU2494108C2 |
| COMPOSITION CONTAINING COMBINATION OF AT LEAST ONE PROTEOLYTIC ENZYME AND AT LEAST ONE LIPOLYTIC ENZYME USED TO PREVENT TRIGLYCERIDE SYNTHESIS | 2011 |
|
RU2536295C2 |
| PEPTIDES OF DIRECTED ACTION OF VEGFR-1/NRP-1 | 2008 |
|
RU2488592C2 |
| APPLICATION o-ATF FOR TREATMENT OF DISEASES INCLUDING ANGIOGENESIS | 2005 |
|
RU2359679C2 |
| AMNIOTIC ADHESIVE CELLS | 2009 |
|
RU2562154C2 |
